About Boston Heart Diagnostics
Boston Heart Diagnostics is a company based in Framingham (United States) founded in 2007 by Bela Asztalos and Ernst Schaefer was acquired by Eurofins Scientific in December 2014. Boston Heart Diagnostics has raised $10.34 million across 2 funding rounds from investors including Eurofins Scientific and Bain Capital Ventures. Boston Heart Diagnostics offers products and services including CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program. Boston Heart Diagnostics operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
- Headquarter Framingham, United States
- Founders Bela Asztalos, Ernst Schaefer
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Boston Heart Diagnostics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.34 M (USD)
in 2 rounds
-
Latest Funding Round
$10.05 M (USD), Series C
Aug 09, 2010
-
Investors
Eurofins Scientific
& 1 more
-
Employee Count
Not available
-
Acquired by
Eurofins Scientific
(Dec 08, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Boston Heart Diagnostics
Boston Heart Diagnostics offers a comprehensive portfolio of products and services, including CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program.
Assesses cardiovascular risk with advanced markers.
Evaluates genetic risks for complex diseases using scores.
Provides comprehensive analysis of lipid metabolism.
Offers convenient fingertip blood tests as an alternative to draws.
Delivers tailored lifestyle management for heart health.
People of Boston Heart Diagnostics
Unlock access to complete
Funding Insights of Boston Heart Diagnostics
Boston Heart Diagnostics has successfully raised a total of $10.34M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $10.05 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Boston Heart Diagnostics
Boston Heart Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eurofins Scientific and Bain Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on investing in multiple sectors
|
Locked | Locked | Locked | |
|
Laboratory testing and contract research services are provided globally.
|
Locked | Locked | Locked |
Investor details for Boston Heart Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boston Heart Diagnostics
Investment portfolio details for Boston Heart Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Boston Heart Diagnostics
Detailed financials for Boston Heart Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Boston Heart Diagnostics Comparisons
Peer comparison for Boston Heart Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Boston Heart Diagnostics
Boston Heart Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Interventional cardiology devices are developed and marketed globally.
|
|
| Locked | Locked | Locked |
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
|
| Locked | Locked | Locked |
Handheld immunodiagnostic devices for cardiac vascular diseases are developed.
|
Detailed competitors of Boston Heart Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Boston Heart Diagnostics
Complete news archive for Boston Heart Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boston Heart Diagnostics
Boston Heart Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Boston Heart Diagnostics is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.
Boston Heart Diagnostics is a funded company, having raised a total of $10.34M across 2 funding rounds to date.
Founded in 2007 and based in Framingham, United States, Boston Heart Diagnostics operates in the healthcare sector, focusing on cardiovascular diagnostics. Proprietary lipid testing, advanced analytical tools, therapy guidelines, and patient support services are provided to physicians, patients, and pharmaceutical companies. These offerings facilitate disease management through integrated diagnostic solutions.
Boston Heart Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
Boston Heart Diagnostics offers CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program.
Boston Heart Diagnostics has 2 investors. Key investors include Eurofins Scientific, and Bain Capital Ventures.